Abstract
A randomized, multi-center study of adult cigarette smokers switched to tobacco-heating cigarettes, snus or ultra-low machine yield tobacco-burning cigarettes (50/group) was conducted, and subjects’ experience with the products was followed for 24 weeks. Differences in biomarkers of tobacco exposure between smokers and never smokers at baseline and among groups relative to each other and over time were assessed. Results indicated reduced exposure to many potentially harmful constituents found in cigarette smoke following product switching. Findings support differences in exposure from the use of various tobacco products and are relevant to the understanding of a risk continuum among tobacco products.
Trial registration: ClinicalTrials.gov identifier: NCT02061917.
Acknowledgements
The authors gratefully acknowledge Betsy Bombick, Gary Byrd, Summer Hanna, David Heavner, Tao Jin, George Krautter, Paul Nelson, Elaine Round, Thomas Steichen, and Weiying Yan.
SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, NC, USA. ® indicates USA registration.
Declaration of interest
All authors are current employees of RAI Services Company or R.J. Reynolds Tobacco Company.
Supplementary material available online
Supplementary Tables 1-4